{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T14:02:15Z","timestamp":1768399335761,"version":"3.49.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Pediatric Infectious Diseases"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1053\/j.spid.2004.09.012","type":"journal-article","created":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T12:33:59Z","timestamp":1107261239000},"page":"50-59","source":"Crossref","is-referenced-by-count":44,"title":["Antiviral therapy of congenital cytomegalovirus infection"],"prefix":"10.1053","volume":"16","author":[{"given":"Mark R.","family":"Schleiss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.spid.2004.09.012_bib1","first-page":"945","article-title":"Uber protozoenartigen Zellen in der Nireeines syphilitischen Neugeboren und in der Parotis von Kindern","volume":"15","author":"Ribbert","year":"1904","journal-title":"Zentralbl Allg Pathol"},{"key":"10.1053\/j.spid.2004.09.012_bib2","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3181\/00379727-92-22498","article-title":"Propagation in tissue cultures of a cytopathogenic virus from human salivary gland virus (SGV) disease","volume":"92","author":"Smith","year":"1956","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1053\/j.spid.2004.09.012_bib3","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3181\/00379727-92-22497","article-title":"Cytopathogenic agent resembling salivary gland virus recovered from tissue cultures of human adenoids","volume":"92","author":"Rowe","year":"1956","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1053\/j.spid.2004.09.012_bib4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3181\/00379727-94-22841","article-title":"Isolation of intranuclear inclusion producing agents from infants with illnesses resembling cytomegalic inclusion disease","volume":"94","author":"Weller","year":"1957","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1053\/j.spid.2004.09.012_bib5","doi-asserted-by":"crossref","unstructured":"Weller TH: The cytomegaloviruses ubiquitous agents with protean clinical manifestations. I. N Engl J Med 1971;285:203\u201314, and II. N Engl J Med 1971;285:267\u201374","DOI":"10.1056\/NEJM197107292850507"},{"key":"10.1053\/j.spid.2004.09.012_bib6","series-title":"Fields Virology","first-page":"2629","article-title":"Cytomegaloviruses and their replication","author":"Mocarski","year":"2001"},{"key":"10.1053\/j.spid.2004.09.012_bib7","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0966-842X(00)01830-8","article-title":"Viral mechanisms of immune evasion","volume":"8","author":"Alcami","year":"2000","journal-title":"Trends Microbiol"},{"key":"10.1053\/j.spid.2004.09.012_bib8","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0966-842X(02)02393-4","article-title":"Immunomodulation by cytomegaloviruses","volume":"10","author":"Mocarski","year":"2000","journal-title":"Trends Microbiol"},{"key":"10.1053\/j.spid.2004.09.012_bib9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1386-6532(01)00184-6","article-title":"The role of cytomegalovirus-encoded homologs of G protein-coupled receptors and chemokines in manipulation of and evasion from the immune system","volume":"23","author":"Vink","year":"2001","journal-title":"J Clin Virol"},{"key":"10.1053\/j.spid.2004.09.012_bib10","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1462-5822.2004.00425.x","article-title":"Immune escape and exploitation strategies of cytomegaloviruses","volume":"6","author":"Mocarski","year":"2004","journal-title":"Cellular Microbiol"},{"key":"10.1053\/j.spid.2004.09.012_bib11","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1159\/000150510","article-title":"Human cytomegalovirus glycoproteins","volume":"39","author":"Britt","year":"1996","journal-title":"Intervirology"},{"key":"10.1053\/j.spid.2004.09.012_bib12","first-page":"135","article-title":"Congenital cytomegalovirus infection and disease","volume":"11","author":"Demmler","year":"1996","journal-title":"Adv Pediatr Infect Dis"},{"key":"10.1053\/j.spid.2004.09.012_bib13","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1471-0528.1984.tb05915.x","article-title":"A prospective study of primary cytomegalovirus infection during pregnancy","volume":"91","author":"Griffiths","year":"1984","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1053\/j.spid.2004.09.012_bib14","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/infdis\/163.3.460","article-title":"Cytomegalovirus infection in sexually active adolescents","volume":"163","author":"Sohn","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1053\/j.spid.2004.09.012_bib15","doi-asserted-by":"crossref","unstructured":"Pass RF, Hutto C, Ricks R, Cloud GA: Increased rate of cytomegalovirus infection among parents of children attending day-care centers. N Engl J Med 314:1414\u20131418, 186","DOI":"10.1056\/NEJM198605293142204"},{"key":"10.1053\/j.spid.2004.09.012_bib16","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00006454-198605000-00008","article-title":"Molecular epidemiology of cytomegalovirus","volume":"5","author":"Adler","year":"1986","journal-title":"Pediatr Infect Dis"},{"key":"10.1053\/j.spid.2004.09.012_bib17","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1001\/jama.1986.03380140079026","article-title":"Cytomegalovirus is not an occupational risk for nurses in renal transplant and neonatal units. Results of a prospective surveillance study","volume":"256","author":"Balfour","year":"1986","journal-title":"JAMA"},{"key":"10.1053\/j.spid.2004.09.012_bib18","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1056\/NEJM198310203091604","article-title":"Occupational risk for primary cytomegalovirus infection among pediatric health-care workers","volume":"309","author":"Dworsky","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1053\/j.spid.2004.09.012_bib19","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1056\/NEJM198511143132006","article-title":"Herpesvirus infections of pregnancy. Part I. Cytomegalovirus and Epstein-Barr virus infections","volume":"313","author":"Stagno","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1053\/j.spid.2004.09.012_bib20","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJM199203053261003","article-title":"The outcome of congenital cytomegalovirus infection in relation to maternal antibody status","volume":"326","author":"Fowler","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1053\/j.spid.2004.09.012_bib21","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1056\/NEJM200105033441804","article-title":"Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity","volume":"344","author":"Boppana","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1053\/j.spid.2004.09.012_bib22","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1080\/00365549950163969","article-title":"Report on a long-term study of maternal and congenital cytomegalovirus infection in Sweden. Review of prospective studies available in the literature","volume":"31","author":"Ahlfors","year":"1999","journal-title":"Scand J Infect Dis"},{"key":"10.1053\/j.spid.2004.09.012_bib23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1542\/peds.104.1.55","article-title":"Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus","volume":"104","author":"Boppana","year":"1999","journal-title":"Pediatrics"},{"key":"10.1053\/j.spid.2004.09.012_bib24","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11940-002-0039-8","article-title":"Congenital cytomegalovirus infection","volume":"4","author":"Bale","year":"2002","journal-title":"Curr Treat Options Neurol"},{"key":"10.1053\/j.spid.2004.09.012_bib25","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1542\/peds.66.5.758","article-title":"Outcome of symptomatic congenital cytomegalovirus infection","volume":"66","author":"Pass","year":"1980","journal-title":"Pediatrics"},{"key":"10.1053\/j.spid.2004.09.012_bib26","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0022-3476(99)70328-8","article-title":"Newborn hearing screening","volume":"135","author":"Fowler","year":"1999","journal-title":"J Pediatr"},{"key":"10.1053\/j.spid.2004.09.012_bib27","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1542\/peds.90.6.862","article-title":"Progressive hearing loss in infants with asymptomatic congenital cytomegalovirus infection","volume":"90","author":"Williamson","year":"1992","journal-title":"Pediatrics"},{"key":"10.1053\/j.spid.2004.09.012_bib28","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1055\/s-0042-1748054","article-title":"Longitudinal investigation of hearing disorders in children with congenital cytomegalovirus","volume":"11","author":"Dahle","year":"2000","journal-title":"J Am Acad Audiol"},{"key":"10.1053\/j.spid.2004.09.012_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10408368609165792","article-title":"Neonatal cytomegalovirus infections due to blood","volume":"23","author":"Adler","year":"1986","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1053\/j.spid.2004.09.012_bib30","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0022-3476(81)80662-2","article-title":"Prevention of transfusion-acquired cytomegalovirus infections in newborn infants","volume":"98","author":"Yeager","year":"1981","journal-title":"J Pediatr"},{"key":"10.1053\/j.spid.2004.09.012_bib31","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1086\/324345","article-title":"Cytomegalovirus infection of extremely low-birth weight infants via breast milk","volume":"33","author":"Maschmann","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.spid.2004.09.012_bib32","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/00006454-200404000-00009","article-title":"Postnatally acquired cytomegalovirus infection via breast milk","volume":"23","author":"Vollmer","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1053\/j.spid.2004.09.012_bib33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1386-6532(99)00065-7","article-title":"Recent advances in the therapy and prevention of CMV infection","volume":"16","author":"Nichols","year":"2000","journal-title":"J Clin Virol"},{"key":"10.1053\/j.spid.2004.09.012_bib34","first-page":"43","article-title":"Cytomegalovirus in immunocompromised persons","volume":"4","author":"Schleiss","year":"2002","journal-title":"Curr Treat Options Infect Dis"},{"key":"10.1053\/j.spid.2004.09.012_bib35","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1053\/spid.2002.29754","article-title":"Antiviral therapy for cytomegalovirus infections in pediatric patients","volume":"13","author":"Kimberlin","year":"2002","journal-title":"Semin Pediatr Infect Dis"},{"key":"10.1053\/j.spid.2004.09.012_bib36","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/jac\/49.2.243","article-title":"The 2001 Garrod lecture. The treatment of cytomegalovirus infection","volume":"49","author":"Griffiths","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1053\/j.spid.2004.09.012_bib37","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jcv.2004.02.009","article-title":"Antiviral drugs in current clinical use","volume":"30","author":"De Clercq","year":"2004","journal-title":"J Clin Virol"},{"key":"10.1053\/j.spid.2004.09.012_bib38","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/358162a0","article-title":"A protein kinase homolog controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells","volume":"358","author":"Sullivan","year":"1992","journal-title":"Nature"},{"key":"10.1053\/j.spid.2004.09.012_bib39","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/358160a0","article-title":"Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir","volume":"358","author":"Littler","year":"1992","journal-title":"Nature"},{"key":"10.1053\/j.spid.2004.09.012_bib40","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1128\/CMR.11.3.533","article-title":"Quantitation of cytomegalovirus","volume":"11","author":"Boeckh","year":"1998","journal-title":"Clin Microbiol Rev"},{"key":"10.1053\/j.spid.2004.09.012_bib41","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1128\/CMR.12.2.286","article-title":"Resistance of human cytomegalovirus to antiviral drugs","volume":"12","author":"Erice","year":"1999","journal-title":"Clin Microbiol Rev"},{"key":"10.1053\/j.spid.2004.09.012_bib42","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/01.mph.0000135283.77668.6a","article-title":"Emergence and compartmentalization of fatal multi-drug resistant cytomegalovirus (CMV) infection in a patient with autosomal-recessive severe combined immune deficiency (SCID)","volume":"26","author":"Blackman","year":"2004","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1053\/j.spid.2004.09.012_bib43","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1386-6532(01)00229-3","article-title":"High dose oral ganciclovir treatment for cytomegalovirus retinitis","volume":"24","author":"Lalezari","year":"2002","journal-title":"J Clin Virol"},{"key":"10.1053\/j.spid.2004.09.012_bib44","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1345\/aph.1A393","article-title":"Valganciclovir","volume":"36","author":"Cocohoba","year":"2002","journal-title":"Ann Pharmacother"},{"key":"10.1053\/j.spid.2004.09.012_bib45","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/01.qco.0000136933.67920.dd","article-title":"Prevention and treatment of cytomegalovirus infection in solid organ transplant recipients","volume":"17","author":"Pereyra","year":"2004","journal-title":"Curr Opin Infect Dis"},{"key":"10.1053\/j.spid.2004.09.012_bib46","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1586\/14787210.2.3.389","article-title":"Overview of congenitally and perinatally acquired cytomegalovirus infections","volume":"2","author":"Schleiss","year":"2004","journal-title":"Expert Rev Anti Infective Ther"},{"key":"10.1053\/j.spid.2004.09.012_bib47","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/375743","article-title":"Viral DNA polymerase mutations associated with drug resistance in human cytomegalovirus","volume":"188","author":"Chou","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1053\/j.spid.2004.09.012_bib48","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/00006454-199501000-00007","article-title":"Use of cytomegalovirus immunoglobulin in multiply transfused premature neonates","volume":"14","author":"Snydman","year":"1995","journal-title":"Pediatr Infect Dis J"},{"key":"10.1053\/j.spid.2004.09.012_bib49","first-page":"466","article-title":"Intraperitoneal administration of cytomegalovirus hyperimmunoglobulin to the cytomegalovirus-infected fetus","volume":"18","author":"Negishi","year":"1998","journal-title":"J Perinatol"},{"key":"10.1053\/j.spid.2004.09.012_bib50","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1034\/j.1399-3062.1999.010204.x","article-title":"Antiviral drug resistance in human cytomegalovirus","volume":"1","author":"Chou","year":"1999","journal-title":"Transpl Infect Dis"},{"key":"10.1053\/j.spid.2004.09.012_bib51","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0166-3542(98)00047-3","article-title":"Mycophenolate mofetil strongly potentiates the anti-herpesvirus activity of acyclovir","volume":"40","author":"Neyts","year":"1998","journal-title":"Antiviral Res"},{"key":"10.1053\/j.spid.2004.09.012_bib52","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1128\/AAC.46.8.2381-2386.2002","article-title":"Alkoxyalkyl esters of cidofovir and cyclic cidofovir exhibit multiple-log enhancement of antiviral activity against cytomegalovirus and herpesvirus replication in vitro","volume":"46","author":"Beadle","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.spid.2004.09.012_bib53","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1086\/421912","article-title":"Oral activity of ether lipid ester prodrugs of cidofovir against experimental human cytomegalovirus infections","volume":"190","author":"Bidanset","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1053\/j.spid.2004.09.012_bib54","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1128\/JVI.72.1.717-725.1998","article-title":"Inhibition of human cytomegalovirus DNA maturation by a benzimidazole ribonucleoside is mediated through the UL89 gene product","volume":"72","author":"Underwood","year":"1998","journal-title":"J Virol"},{"key":"10.1053\/j.spid.2004.09.012_bib55","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.1128\/JVI.72.6.4721-4728.1998","article-title":"Resistance of human cytomegalovirus to benzimidazole ribonucleosides maps to two open reading frames","volume":"72","author":"Krosky","year":"1998","journal-title":"J Virol"},{"issue":"2","key":"10.1053\/j.spid.2004.09.012_bib56","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0166-3542(03)00108-6","article-title":"DNA encapsidation as a target for anti-herpesvirus drug therapy","volume":"59","author":"Visalli","year":"2003","journal-title":"Antiviral Res"},{"key":"10.1053\/j.spid.2004.09.012_bib57","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1128\/AAC.46.8.2365-2372.2002","article-title":"Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action","volume":"46","author":"Biron","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.spid.2004.09.012_bib58","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1128\/AAC.46.8.2373-2380.2002","article-title":"Preclinical and toxicology studies of 1263W94, a potent and selective inhibitor of human cytomegalovirus replication","volume":"46","author":"Koszalka","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.spid.2004.09.012_bib59","doi-asserted-by":"crossref","first-page":"9077","DOI":"10.1128\/JVI.75.19.9077-9086.2001","article-title":"A novel nonnucleoside inhibitor specifically targets cytomegalovirus DNA maturation via the UL89 and UL56 gene products","volume":"75","author":"Buerger","year":"2001","journal-title":"J Virol"},{"key":"10.1053\/j.spid.2004.09.012_bib60","unstructured":"Nagelschmitz, J, Moeller, JG, Stass, H, et al: Safety, tolerability and pharmacokinetics of single oral doses of BAY 38-4766\u2013a novel, non-nucleosidic inhibitor of human cytomegalovirus replication\u2013in healthy male subjects. Proceedings of the 39th ICAAC; 1999 Sep 26-29; San Francisco [abstract no. 945]"},{"key":"10.1053\/j.spid.2004.09.012_bib61","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1159\/000053979","article-title":"Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide","volume":"42","author":"Waldman","year":"1999","journal-title":"Intervirology"},{"key":"10.1053\/j.spid.2004.09.012_bib62","first-page":"372","article-title":"Treatment of congenital cytomegalic inclusion disease with antiviral agents","volume":"9","author":"Plotkin","year":"1969","journal-title":"Antimicrobial Agents Chemother"},{"key":"10.1053\/j.spid.2004.09.012_bib63","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1542\/peds.48.2.318","article-title":"Floxuridine treatment of congenital cytomegalic inclusion disease","volume":"48","author":"Feigin","year":"1971","journal-title":"Pediatrics"},{"key":"10.1053\/j.spid.2004.09.012_bib64","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0022-3476(72)80514-6","article-title":"Experimental use of cytosine arabinoside in congenital cytomegalovirus infection","volume":"80","author":"Kraybill","year":"1972","journal-title":"J Pediatr"},{"key":"10.1053\/j.spid.2004.09.012_bib65","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0022-3476(72)80515-8","article-title":"Cytosine arabinoside in the treatment of congenital cytomegalic inclusion disease","volume":"80","author":"McCracken","year":"1972","journal-title":"J Pediatr"},{"key":"10.1053\/j.spid.2004.09.012_bib66","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/00006454-199010000-00013","article-title":"Ganciclovir therapy of congenital cytomegalovirus pneumonia","volume":"9","author":"Hocker","year":"1990","journal-title":"Pediatr Infect Dis J"},{"key":"10.1053\/j.spid.2004.09.012_bib67","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3109\/00365549309008515","article-title":"Ganciclovir treatment of congenital cytomegalovirus infection","volume":"25","author":"Attard-Montalto","year":"1993","journal-title":"Scand J Infect Dis"},{"key":"10.1053\/j.spid.2004.09.012_bib68","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1651-2227.1995.tb13641.x","article-title":"Ganciclovir therapy of congenital human cytomegalovirus hepatitis","volume":"84","author":"Stronati","year":"1995","journal-title":"Acta Paediatr"},{"key":"10.1053\/j.spid.2004.09.012_bib69","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/00006454-199403000-00019","article-title":"Ganciclovir treatment of steroid-associated cytomegalovirus disease in a congenitally infected neonate","volume":"13","author":"Vallejo","year":"1994","journal-title":"Pediatr Infect Dis J"},{"key":"10.1053\/j.spid.2004.09.012_bib70","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/00006454-199103000-00023","article-title":"Immune responses after ganciclovir and immunoglobulin therapy of infants","volume":"10","author":"Junker","year":"1991","journal-title":"Pediatr Infect Dis J"},{"key":"10.1053\/j.spid.2004.09.012_bib71","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1651-2227.1992.tb12341.x","article-title":"Ganciclovir therapy of congenital cytomegalovirus disease","volume":"81","author":"Reigstad","year":"1992","journal-title":"Acta Paediatr"},{"key":"10.1053\/j.spid.2004.09.012_bib72","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/01.inf.0000069767.43169.2d","article-title":"Treatment of children with congenital cytomegalovirus infection with ganciclovir","volume":"22","author":"Michaels","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.1053\/j.spid.2004.09.012_bib73","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0022-3476(94)70327-2","article-title":"Ganciclovir therapy for symptomatic congenital cytomegalovirus infection in infants","volume":"124","author":"Nigro","year":"1994","journal-title":"J Pediatr"},{"key":"10.1053\/j.spid.2004.09.012_bib74","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/jac\/dkf144","article-title":"Ganciclovir treatment of symptomatic congenital cytomegalovirus infection","volume":"50","author":"Crowley","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"10.1053\/j.spid.2004.09.012_bib75","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s007050050103","article-title":"Ganciclovir therapy for cytomegalovirus-associated liver disease in immunocompetent or immunocompromised children","volume":"142","author":"Nigro","year":"1997","journal-title":"Arch Virol"},{"key":"10.1053\/j.spid.2004.09.012_bib76","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/00005176-200202000-00009","article-title":"Ganciclovir treatment in infants with cytomegalovirus infection and cholestasis","volume":"34","author":"Fischler","year":"2002","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1053\/j.spid.2004.09.012_bib77","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/clpt.1993.4","article-title":"Linear single-dose pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections","volume":"53","author":"Trang","year":"1993","journal-title":"Clin Pharmacol Ther"},{"key":"10.1053\/j.spid.2004.09.012_bib78","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1128\/AAC.40.9.2202","article-title":"Population pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections","volume":"40","author":"Zhou","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.spid.2004.09.012_bib79","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1086\/516445","article-title":"Ganciclovir treatment of symptomatic congenital cytomegalovirus infection","volume":"175","author":"Whitley","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1053\/j.spid.2004.09.012_bib80","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0022-3476(03)00192-6","article-title":"Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system","volume":"143","author":"Kimberlin","year":"2003","journal-title":"J Pediatr"},{"key":"10.1053\/j.spid.2004.09.012_bib81","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/00006454-199708000-00014","article-title":"Concurrent ganciclovir and foscarnet treatment for cytomegalovirus encephalitis and retinitis in an infant with acquired immunodeficiency syndrome","volume":"16","author":"Zaknun","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"10.1053\/j.spid.2004.09.012_bib82","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM199411033311801","article-title":"Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Groupz","volume":"331","author":"Connor","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1053\/j.spid.2004.09.012_bib83","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/00000441-199309000-00004","article-title":"Ganciclovir transfer by human placenta and its effects on rat fetal cells","volume":"306","author":"Henderson","year":"1993","journal-title":"Am J Med Sci"},{"key":"10.1053\/j.spid.2004.09.012_bib84","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0002-9378(94)70089-3","article-title":"The transfer of the nucleoside analog ganciclovir across the perfused human placenta","volume":"170","author":"Gilstrap","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1053\/j.spid.2004.09.012_bib85","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1053\/spid.2001.24097","article-title":"New antiviral therapeutic agents","volume":"12","author":"Kimberlin","year":"2001","journal-title":"Semin Pediatr Infect Dis"},{"key":"10.1053\/j.spid.2004.09.012_bib86","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1097\/00007890-199903150-00021","article-title":"Absence of teratogenicity of oral ganciclovir used during early pregnancy in a liver transplant recipient","volume":"67","author":"Pescovitz","year":"1999","journal-title":"Transplantation"},{"key":"10.1053\/j.spid.2004.09.012_bib87","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/clinids\/20.1.52","article-title":"Congenital cytomegalovirus infection in offspring of liver transplant recipients","volume":"20","author":"Laifer","year":"1995","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.spid.2004.09.012_bib88","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1080\/00365549850160981","article-title":"Severe cytomegalovirus hepatitis in a pregnant woman treated with ganciclovir","volume":"30","author":"Miguelez","year":"1998","journal-title":"Scand J Infect Dis"},{"key":"10.1053\/j.spid.2004.09.012_bib89","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0928-0197(93)90034-3","article-title":"Prenatal treatment of congenital human cytomegalovirus infection by fetal intravascular administration of ganciclovir","volume":"1","author":"Revello","year":"1993","journal-title":"Clin Diagn Virol"},{"key":"10.1053\/j.spid.2004.09.012_bib90","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1097\/00006454-200208000-00023","article-title":"Placental transfer of ganciclovir in a woman with acquired immunodeficiency syndrome and cytomegalovirus disease","volume":"21","author":"Brady","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1053\/j.spid.2004.09.012_bib91","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/j.1471-0528.2004.00179.x","article-title":"Intrauterine therapy for a cytomegalovirus-infected symptomatic fetus","volume":"111","author":"Matsuda","year":"2004","journal-title":"BJOG"},{"key":"10.1053\/j.spid.2004.09.012_bib92","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1128\/JCM.37.10.3350-3352.1999","article-title":"Quantification of human cytomegalovirus DNA in amniotic fluid of mothers of congenitally infected fetuses","volume":"37","author":"Revello","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1053\/j.spid.2004.09.012_bib93","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00006454-199603000-00013","article-title":"Prevention of child-to-mother transmission of cytomegalovirus by changing behaviors","volume":"15","author":"Adler","year":"1996","journal-title":"Pediatr Infect Dis J"},{"key":"10.1053\/j.spid.2004.09.012_bib94","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1086\/421999","article-title":"Vaccine Development to Prevent Cytomegalovirus Disease","volume":"39","author":"Arvin","year":"2004","journal-title":"Clin Infect Dis"}],"container-title":["Seminars in Pediatric Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045187004000925?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045187004000925?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T22:48:29Z","timestamp":1682981309000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045187004000925"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S1045187004000925"],"URL":"https:\/\/doi.org\/10.1053\/j.spid.2004.09.012","relation":{},"ISSN":["1045-1870"],"issn-type":[{"value":"1045-1870","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}